Business
PURE Bioscience Sets Q3 Results Conference Call to Update Progress of FDA Approved PURE Control® Antimicrobial and the Company’s Food Safety Solutions Strategy
PURE Bioscience Sets Q3 Results Conference Call to Update Progress of FDA Approved PURE Control® Antimicrobial and the Company’s Food Safety Solutions Strategy.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented silver dihydrogen citrate (SDC) \n antimicrobial, announced today that on June 9, 2016 the Company will \n file its Form 10-Q shortly after the close of the market and host an \n investor conference call that day at 1:30pm PDT (4:30pm EDT) to review \n fiscal third quarter financial results.\n \n \n In addition to discussion of financial results, the PURE management team \n will review the progress made to commercialize SDC as a food safety \n solution – including the status of the USDA in-plant trial for PURE \n Control® as a raw poultry processing aid.\n \n \n The Participant Dial-In Number for the conference call is \n 1-631-891-4304. Participants should dial in to the call at least five \n minutes before 1:30pm PDT (4:30pm EDT) on June 9, 2016. The call can \n also be accessed “live” online at http://public.viavid.com/index.php?id=119761.\n \n \n A replay of the webcast will be available on the Company’s website (http://www.purebio.com/about/investor_relations). \n Also, a replay of the conference call will be available by dialing \n 1-877-870-5176 (international participants dial 1-858-384-5517) starting \n June 9, 2016, at 7:30pm Eastern Time through June 16, 2016 at 11:59pm \n Eastern Time. Please use PIN Number 10001242.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety \n arena -- providing solutions to the health and environmental challenges \n of pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic \n antimicrobial agent, which offers 24-hour residual protection and \n formulates well with other compounds. As a platform technology, SDC is \n distinguished from existing products in the marketplace because of its \n superior efficacy, reduced toxicity and the inability of bacteria to \n form a resistance to it. PURE is headquartered in El Cajon, California \n (San Diego metropolitan area). Additional information on PURE is \n available at www.purebio.com.\n \n \n Forward-looking Statements\n \n \n Any statements contained in this press rel...